4.8 Article

Towards programming immune tolerance through geometric manipulation of phosphatidylserine

期刊

BIOMATERIALS
卷 72, 期 -, 页码 1-10

出版社

ELSEVIER SCI LTD
DOI: 10.1016/j.biomaterials.2015.08.040

关键词

Autoimmunity; Immunoengineering; Immunomodulation; Nanoparticles; PRINT; PLGA; Phosphatidylserine; Tolerance; Transplantation

资金

  1. NC TRACS [100K1202]
  2. NIH [U19AI109784, 8-VP1-CA174425-04, T32-AI007273-25]
  3. UCRF UNC
  4. Cancer Research Institute
  5. National Defense Science and Engineering Graduate Fellowship
  6. PhRMA Foundation
  7. University Cancer Research Fund
  8. UNC Medical Scientists Training Program [NIGMS-2-T32-GM008719]
  9. [CA1068-A-10]

向作者/读者索取更多资源

The possibility of engineering the immune system in a targeted fashion using biomaterials such as nanoparticles has made considerable headway in recent years. However, little is known as to how modulating the spatial presentation of a ligand augments downstream immune responses. In this report we show that geometric manipulation of phosphatidylserine (PS) through fabrication on rod-shaped PLGA nanoparticles robustly dampens inflammatory responses from innate immune cells while promoting T regulatory cell abundance by impeding effector T cell expansion. This response depends on the geometry of PS presentation as both PS liposomes and 1 micron cylindrical PS-PLGA particles are less potent signal inducers than 80 x 320 nm rod-shaped PS-PLGA particles for an equivalent dose of PS. We show that this immune tolerizing effect can be co-opted for therapeutic benefit in a mouse model of multiple sclerosis and an assay of organ rejection using a mixed lymphocyte reaction with primary human immune cells. These data provide evidence that geometric manipulation of a ligand via biomaterials may enable more efficient and tunable programming of cellular signaling networks for therapeutic benefit in a variety of disease states, including autoimmunity and organ rejection, and thus should be an active area of further research. (C) 2015 Published by Elsevier Ltd.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据